This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Guangzhou Ribobio Co., Ltd.. Active years: 2020.
Company Filing History:
1 out of 3,334 
1 out of 2 Years Active: 2020
Title: Xiuqun Yang: Innovator in RNA Therapeutics
Introduction
Xiuqun Yang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of RNA therapeutics, particularly in the development of methods for inhibiting specific gene expressions associated with various diseases.
Latest Patents
Yang holds a patent for "Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM17." This patent involves the use of siRNAs or chemically-modified siRNAs targeted against ADAMTS-5 or ADAM17. These innovations aim to inhibit the expression of these genes, which are linked to diseases such as arthritis and other inflammation-related conditions. The patent outlines methods for administering these siRNAs into the articular cavity of patients to treat associated diseases.
Career Highlights
Throughout his career, Xiuqun Yang has worked with esteemed organizations, including the Chinese Academy of Sciences and Guangzhou Ribobio Co., Ltd. His work has been instrumental in advancing the understanding and treatment of inflammation-related diseases through innovative RNA-based therapies.
Collaborations
Yang has collaborated with notable professionals in his field, including Bill Biliang Zhang and Micky D Tortorella. These collaborations have further enriched his research and contributed to the development of effective therapeutic strategies.
Conclusion
Xiuqun Yang's contributions to RNA therapeutics and his innovative approaches to treating inflammation-related diseases highlight his importance in the field of medical research. His work continues to pave the way for advancements in gene therapy and patient care.